Breast cancer - management of resistant disease papers from a European School of Oncology task force workshop ; 6 September 1994, Amsterdam, The Netherlands

Gespeichert in:
Bibliographische Detailangaben
Format: Buch
Sprache:English
Veröffentlicht: Oxford [u.a] Pergamon 1995
Schriftenreihe:[European journal of cancer / A / Supplement] 31,7
Schlagworte:
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

MARC

LEADER 00000nam a2200000 cb4500
001 BV010515955
003 DE-604
005 19961025
007 t|
008 951207s1995 xx |||| 10||| eng d
035 |a (OCoLC)69002999 
035 |a (DE-599)BVBBV010515955 
040 |a DE-604  |b ger  |e rakddb 
041 0 |a eng 
049 |a DE-19  |a DE-29  |a DE-12  |a DE-20 
084 |a XH 3200  |0 (DE-625)152888:12905  |2 rvk 
084 |a XH 8450  |0 (DE-625)152958:13129  |2 rvk 
245 1 0 |a Breast cancer - management of resistant disease  |b papers from a European School of Oncology task force workshop ; 6 September 1994, Amsterdam, The Netherlands 
264 1 |a Oxford [u.a]  |b Pergamon  |c 1995 
300 |a 24 S. 
336 |b txt  |2 rdacontent 
337 |b n  |2 rdamedia 
338 |b nc  |2 rdacarrier 
490 1 |a [European journal of cancer / A / Supplement]  |v 31,7 
650 7 |a Borstkanker  |2 gtt 
650 0 7 |a Therapieresistenz  |0 (DE-588)4133317-2  |2 gnd  |9 rswk-swf 
650 0 7 |a Krebs  |g Medizin  |0 (DE-588)4073781-0  |2 gnd  |9 rswk-swf 
650 0 7 |a Brustkrebs  |0 (DE-588)4008528-4  |2 gnd  |9 rswk-swf 
650 0 7 |a Chemotherapie  |0 (DE-588)4127083-6  |2 gnd  |9 rswk-swf 
650 0 7 |a Arzneimittelresistenz  |0 (DE-588)4143180-7  |2 gnd  |9 rswk-swf 
650 0 7 |a Cytostatikum  |0 (DE-588)4068347-3  |2 gnd  |9 rswk-swf 
655 7 |0 (DE-588)1071861417  |a Konferenzschrift  |y 1994  |z Amsterdam  |2 gnd-content 
655 7 |a Congressen (vorm)  |2 gtt 
689 0 0 |a Brustkrebs  |0 (DE-588)4008528-4  |D s 
689 0 1 |a Chemotherapie  |0 (DE-588)4127083-6  |D s 
689 0 2 |a Therapieresistenz  |0 (DE-588)4133317-2  |D s 
689 0 |5 DE-604 
689 1 0 |a Krebs  |g Medizin  |0 (DE-588)4073781-0  |D s 
689 1 1 |a Cytostatikum  |0 (DE-588)4068347-3  |D s 
689 1 2 |a Arzneimittelresistenz  |0 (DE-588)4143180-7  |D s 
689 1 |5 DE-604 
710 2 |a European School of Oncology  |e Sonstige  |0 (DE-588)2087039-5  |4 oth 
810 2 |a A / Supplement]  |t [European journal of cancer  |v 31,7  |w (DE-604)BV008922295  |9 31,7 
943 1 |a oai:aleph.bib-bvb.de:BVB01-007009482 

Datensatz im Suchindex

_version_ 1819240080633495553
any_adam_object
building Verbundindex
bvnumber BV010515955
classification_rvk XH 3200
XH 8450
ctrlnum (OCoLC)69002999
(DE-599)BVBBV010515955
discipline Medizin
format Book
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01978nam a2200493 cb4500</leader><controlfield tag="001">BV010515955</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">19961025 </controlfield><controlfield tag="007">t|</controlfield><controlfield tag="008">951207s1995 xx |||| 10||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)69002999</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV010515955</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield><subfield code="a">DE-29</subfield><subfield code="a">DE-12</subfield><subfield code="a">DE-20</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XH 3200</subfield><subfield code="0">(DE-625)152888:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XH 8450</subfield><subfield code="0">(DE-625)152958:13129</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Breast cancer - management of resistant disease</subfield><subfield code="b">papers from a European School of Oncology task force workshop ; 6 September 1994, Amsterdam, The Netherlands</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Oxford [u.a]</subfield><subfield code="b">Pergamon</subfield><subfield code="c">1995</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">24 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">[European journal of cancer / A / Supplement]</subfield><subfield code="v">31,7</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Borstkanker</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Therapieresistenz</subfield><subfield code="0">(DE-588)4133317-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Brustkrebs</subfield><subfield code="0">(DE-588)4008528-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Chemotherapie</subfield><subfield code="0">(DE-588)4127083-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelresistenz</subfield><subfield code="0">(DE-588)4143180-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1994</subfield><subfield code="z">Amsterdam</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="a">Congressen (vorm)</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Brustkrebs</subfield><subfield code="0">(DE-588)4008528-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Chemotherapie</subfield><subfield code="0">(DE-588)4127083-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Therapieresistenz</subfield><subfield code="0">(DE-588)4133317-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Arzneimittelresistenz</subfield><subfield code="0">(DE-588)4143180-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">European School of Oncology</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)2087039-5</subfield><subfield code="4">oth</subfield></datafield><datafield tag="810" ind1="2" ind2=" "><subfield code="a">A / Supplement]</subfield><subfield code="t">[European journal of cancer</subfield><subfield code="v">31,7</subfield><subfield code="w">(DE-604)BV008922295</subfield><subfield code="9">31,7</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-007009482</subfield></datafield></record></collection>
genre (DE-588)1071861417 Konferenzschrift 1994 Amsterdam gnd-content
Congressen (vorm) gtt
genre_facet Konferenzschrift 1994 Amsterdam
Congressen (vorm)
id DE-604.BV010515955
illustrated Not Illustrated
indexdate 2024-12-23T14:02:20Z
institution BVB
institution_GND (DE-588)2087039-5
language English
oai_aleph_id oai:aleph.bib-bvb.de:BVB01-007009482
oclc_num 69002999
open_access_boolean
owner DE-19
DE-BY-UBM
DE-29
DE-12
DE-20
owner_facet DE-19
DE-BY-UBM
DE-29
DE-12
DE-20
physical 24 S.
publishDate 1995
publishDateSearch 1995
publishDateSort 1995
publisher Pergamon
record_format marc
series2 [European journal of cancer / A / Supplement]
spelling Breast cancer - management of resistant disease papers from a European School of Oncology task force workshop ; 6 September 1994, Amsterdam, The Netherlands
Oxford [u.a] Pergamon 1995
24 S.
txt rdacontent
n rdamedia
nc rdacarrier
[European journal of cancer / A / Supplement] 31,7
Borstkanker gtt
Therapieresistenz (DE-588)4133317-2 gnd rswk-swf
Krebs Medizin (DE-588)4073781-0 gnd rswk-swf
Brustkrebs (DE-588)4008528-4 gnd rswk-swf
Chemotherapie (DE-588)4127083-6 gnd rswk-swf
Arzneimittelresistenz (DE-588)4143180-7 gnd rswk-swf
Cytostatikum (DE-588)4068347-3 gnd rswk-swf
(DE-588)1071861417 Konferenzschrift 1994 Amsterdam gnd-content
Congressen (vorm) gtt
Brustkrebs (DE-588)4008528-4 s
Chemotherapie (DE-588)4127083-6 s
Therapieresistenz (DE-588)4133317-2 s
DE-604
Krebs Medizin (DE-588)4073781-0 s
Cytostatikum (DE-588)4068347-3 s
Arzneimittelresistenz (DE-588)4143180-7 s
European School of Oncology Sonstige (DE-588)2087039-5 oth
A / Supplement] [European journal of cancer 31,7 (DE-604)BV008922295 31,7
spellingShingle Breast cancer - management of resistant disease papers from a European School of Oncology task force workshop ; 6 September 1994, Amsterdam, The Netherlands
Borstkanker gtt
Therapieresistenz (DE-588)4133317-2 gnd
Krebs Medizin (DE-588)4073781-0 gnd
Brustkrebs (DE-588)4008528-4 gnd
Chemotherapie (DE-588)4127083-6 gnd
Arzneimittelresistenz (DE-588)4143180-7 gnd
Cytostatikum (DE-588)4068347-3 gnd
subject_GND (DE-588)4133317-2
(DE-588)4073781-0
(DE-588)4008528-4
(DE-588)4127083-6
(DE-588)4143180-7
(DE-588)4068347-3
(DE-588)1071861417
title Breast cancer - management of resistant disease papers from a European School of Oncology task force workshop ; 6 September 1994, Amsterdam, The Netherlands
title_auth Breast cancer - management of resistant disease papers from a European School of Oncology task force workshop ; 6 September 1994, Amsterdam, The Netherlands
title_exact_search Breast cancer - management of resistant disease papers from a European School of Oncology task force workshop ; 6 September 1994, Amsterdam, The Netherlands
title_full Breast cancer - management of resistant disease papers from a European School of Oncology task force workshop ; 6 September 1994, Amsterdam, The Netherlands
title_fullStr Breast cancer - management of resistant disease papers from a European School of Oncology task force workshop ; 6 September 1994, Amsterdam, The Netherlands
title_full_unstemmed Breast cancer - management of resistant disease papers from a European School of Oncology task force workshop ; 6 September 1994, Amsterdam, The Netherlands
title_short Breast cancer - management of resistant disease
title_sort breast cancer management of resistant disease papers from a european school of oncology task force workshop 6 september 1994 amsterdam the netherlands
title_sub papers from a European School of Oncology task force workshop ; 6 September 1994, Amsterdam, The Netherlands
topic Borstkanker gtt
Therapieresistenz (DE-588)4133317-2 gnd
Krebs Medizin (DE-588)4073781-0 gnd
Brustkrebs (DE-588)4008528-4 gnd
Chemotherapie (DE-588)4127083-6 gnd
Arzneimittelresistenz (DE-588)4143180-7 gnd
Cytostatikum (DE-588)4068347-3 gnd
topic_facet Borstkanker
Therapieresistenz
Krebs Medizin
Brustkrebs
Chemotherapie
Arzneimittelresistenz
Cytostatikum
Konferenzschrift 1994 Amsterdam
Congressen (vorm)
volume_link (DE-604)BV008922295
work_keys_str_mv AT europeanschoolofoncology breastcancermanagementofresistantdiseasepapersfromaeuropeanschoolofoncologytaskforceworkshop6september1994amsterdamthenetherlands